- Home
- FOF vs CYRX Comparison
FOF vs CYRX Comparison
Compare FOF & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FOF | CYRX |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 394.4M | 421.6M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | FOF | CYRX |
|---|---|---|
| Price | $14.08 | $7.84 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.94 |
| AVG Volume (30 Days) | 80.5K | ★ 358.4K |
| Earning Date | 01-01-0001 | 06-04-2026 |
| Dividend Yield | ★ 9.07% | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | N/A | ★ 1.40 |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | N/A | $9.71 |
| Revenue Next Year | N/A | $9.56 |
| P/E Ratio | ★ N/A | $5.75 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.97 | $4.63 |
| 52 Week High | $15.04 | $11.45 |
Technical Indicators
Market Signals| Indicator | FOF | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 38.97 | 35.31 |
| Support Level | $12.87 | $6.57 |
| Resistance Level | $14.50 | $8.45 |
| Average True Range (ATR) | 0.19 | 0.49 |
| MACD | -0.07 | 0.02 |
| Stochastic Oscillator | 13.48 | 17.14 |
Price Performance
Historical ComparisonAbout FOF Cohen & Steers Closed-End Opportunity Fund Inc.
Cohen & Steers Closed-end Opp Fd Inc is a diversified, closed-ended management investment company. Its investment objective is to achieve a total return, consisting of high current income and potential capital appreciation.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.